GlobalData projects ACAM2000 will generate $121m in revenue in 2024, increasing to $129m annually by 2030. GlobalData is the parent company of Pharmaceutical Technology.. The Bora deal follows ...

Hi, it’s Pei Li in Hong Kong, where I spoke with the founder and CEO of Bora Pharmaceuticals about the Taiwanese company’s M&A strategy as it seeks to become a major player in the health-care ...

Bora Pharmaceuticals Co., Ltd. ("Bora" or "the Company", TWSE: 6472), today announced that its Board of Directors has approved the acquisition of US-based Pyros Pharmaceuticals, Inc. ("Pyros"), a ...

Bora Pharmaceuticals thinks it’s found a contract manufacturing niche as it works join the ranks of the world's top 10 CDMOs over the next five years.

Bora Pharmaceuticals, a contract development and manufacturing organization, announced on Oct. 15, 2020 that its chairman and CEO, Bobby Sheng, was named ‘CEO of the Year’ at the CPhI Pharma Awards ...

HONG KONG SAR - Media OutReach Newswire - 14 May 2025 - Bora Pharmaceuticals (TWSE: 6472) ... EPS from continuing operations reached NT$26.54, reflecting NT$2.44 billion of net non-operating income ...